Location: Home > Pharma China Web Edition
  • search
  • go
    • Industry News
    TEVA moves into China through acquisitions 9/8/2005
    TEVA will acquire Tianjin Hualida Biopharmaceutical Ltd., a companies specializing in generic biopharmaceuticals.  Currently TEVA owns 45% of Tianjin Hualida through SICOR, which was taken over by TEVA in 2004.
     
    TEVA will also obtain 50% of Kunming Baker Norton Pharmaceuticals through its acquisition of IVAX in the USA.
    Relate News
    more
  • Site map | Contact Us | Links
  • © Wicon International Group